RxDoctor Payments Data

Logan Rummells

Family · Newbern, TNNPI 1851098164

Payments from drug & device makers

$1,510in general payments, 2019–2025

Across 89 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$639
  • AbbVie$305
  • Boehringer Ingelheim$293
  • Lilly USA, LLC$96
  • AstraZeneca$95
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$37
  • plus $45 from 2 others

What the payments were for

  • Food & beverage$1,510100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,510 in reported general payments places this provider in the 70th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$4,707
Medicare patients
91
Services billed
266

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin79$59,539
OzempicSemaglutide33$39,179
MounjaroTirzepatide33$33,598
EliquisApixaban29$22,317
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$15,396
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$13,381
LinzessLinaclotide17$8,990
TradjentaLinagliptin14$7,567
XareltoRivaroxaban11$6,730
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,094
Atorvastatin Calcium140$1,427
Losartan Potassium157$1,317
SynthroidLevothyroxine Sodium21$1,045
Omeprazole66$984
Albuterol Sulfate HfaAlbuterol Sulfate40$884

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$293$67,10693 claims
Novo NordiskOzempic$639$39,17933 claims
Lilly USA, LLCMounjaro$96$33,59833 claims
AstraZenecaBreztri Aerosphere$95$13,38120 claims
AbbVieLinzess, Synthroid$305$10,03538 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,706 family providers in Tennessee.

Other family in Newbern

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →